Shexiang Baoxin Pills Could Alleviate Isoproterenol-Induced Heart Failure Probably through its Inhibition of CaV1.2 Calcium Channel Currents

Heart failure (HF) affects millions of patients in the world. Shexiang Baoxin Pills (SXB) are extensively applied to treat coronary artery diseases and HF in Chinese hospitals. However, there are still no explanations for why SXB protects against HF. To assess the protective role, we created the HF...

Full description

Saved in:
Bibliographic Details
Main Authors: Jianwei Wu, Juan Yu, Jianyong Qi, Minzhou Zhang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Biochemistry Research International
Online Access:http://dx.doi.org/10.1155/2022/5498023
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850166455419535360
author Jianwei Wu
Juan Yu
Jianyong Qi
Minzhou Zhang
author_facet Jianwei Wu
Juan Yu
Jianyong Qi
Minzhou Zhang
author_sort Jianwei Wu
collection DOAJ
description Heart failure (HF) affects millions of patients in the world. Shexiang Baoxin Pills (SXB) are extensively applied to treat coronary artery diseases and HF in Chinese hospitals. However, there are still no explanations for why SXB protects against HF. To assess the protective role, we created the HF model in rats by isoproterenol (ISO) subcutaneous injection, 85 milligrams per kilogram body weight for seven days. Four groups were implemented: CON (control), ISO (HF disease group), CAP (captopril, positive drug treatment), and SXB groups. Echocardiography was used to evaluate rats’ HF in vivo. The human CaV1.2 (hCaV1.2) channel currents were detected in tsA-201 cells by patch clamp technique. Five different concentrations of SXB (5, 10, 30, 50, and 100 mg/L) were chosen in this study. The results showed that SXB increased cardiac systolic function and inhibited rats’ cardiac hypertrophy and myocardial fibrosis induced by ISO. Subsequently, it was found that SXB was inhibited by the peak amplitudes of hCaV1.2 channel current (P<0.01). The SXB half inhibitory dosage was 9.09 mg/L. The steady-state activation curve was 22.8 mV depolarization shifted; while the inactivation curve and the recovery from inactivation were not affected significantly. In conclusion, these results indicated that SXB inhibited ISO-induced HF in rats and inhibited the hCaV1.2 channel current. The present study paved the way for SXB to protect itself from HF.
format Article
id doaj-art-d9d8a5e0ee85490993f00dc85079a847
institution OA Journals
issn 2090-2255
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Biochemistry Research International
spelling doaj-art-d9d8a5e0ee85490993f00dc85079a8472025-08-20T02:21:25ZengWileyBiochemistry Research International2090-22552022-01-01202210.1155/2022/5498023Shexiang Baoxin Pills Could Alleviate Isoproterenol-Induced Heart Failure Probably through its Inhibition of CaV1.2 Calcium Channel CurrentsJianwei Wu0Juan Yu1Jianyong Qi2Minzhou Zhang3Affiliated Hospital of Guangzhou University of Chinese MedicineAffiliated Hospital of Guangzhou University of Chinese MedicineIntensive Care Research Team of Traditional Chinese MedicineIntensive Care Research Team of Traditional Chinese MedicineHeart failure (HF) affects millions of patients in the world. Shexiang Baoxin Pills (SXB) are extensively applied to treat coronary artery diseases and HF in Chinese hospitals. However, there are still no explanations for why SXB protects against HF. To assess the protective role, we created the HF model in rats by isoproterenol (ISO) subcutaneous injection, 85 milligrams per kilogram body weight for seven days. Four groups were implemented: CON (control), ISO (HF disease group), CAP (captopril, positive drug treatment), and SXB groups. Echocardiography was used to evaluate rats’ HF in vivo. The human CaV1.2 (hCaV1.2) channel currents were detected in tsA-201 cells by patch clamp technique. Five different concentrations of SXB (5, 10, 30, 50, and 100 mg/L) were chosen in this study. The results showed that SXB increased cardiac systolic function and inhibited rats’ cardiac hypertrophy and myocardial fibrosis induced by ISO. Subsequently, it was found that SXB was inhibited by the peak amplitudes of hCaV1.2 channel current (P<0.01). The SXB half inhibitory dosage was 9.09 mg/L. The steady-state activation curve was 22.8 mV depolarization shifted; while the inactivation curve and the recovery from inactivation were not affected significantly. In conclusion, these results indicated that SXB inhibited ISO-induced HF in rats and inhibited the hCaV1.2 channel current. The present study paved the way for SXB to protect itself from HF.http://dx.doi.org/10.1155/2022/5498023
spellingShingle Jianwei Wu
Juan Yu
Jianyong Qi
Minzhou Zhang
Shexiang Baoxin Pills Could Alleviate Isoproterenol-Induced Heart Failure Probably through its Inhibition of CaV1.2 Calcium Channel Currents
Biochemistry Research International
title Shexiang Baoxin Pills Could Alleviate Isoproterenol-Induced Heart Failure Probably through its Inhibition of CaV1.2 Calcium Channel Currents
title_full Shexiang Baoxin Pills Could Alleviate Isoproterenol-Induced Heart Failure Probably through its Inhibition of CaV1.2 Calcium Channel Currents
title_fullStr Shexiang Baoxin Pills Could Alleviate Isoproterenol-Induced Heart Failure Probably through its Inhibition of CaV1.2 Calcium Channel Currents
title_full_unstemmed Shexiang Baoxin Pills Could Alleviate Isoproterenol-Induced Heart Failure Probably through its Inhibition of CaV1.2 Calcium Channel Currents
title_short Shexiang Baoxin Pills Could Alleviate Isoproterenol-Induced Heart Failure Probably through its Inhibition of CaV1.2 Calcium Channel Currents
title_sort shexiang baoxin pills could alleviate isoproterenol induced heart failure probably through its inhibition of cav1 2 calcium channel currents
url http://dx.doi.org/10.1155/2022/5498023
work_keys_str_mv AT jianweiwu shexiangbaoxinpillscouldalleviateisoproterenolinducedheartfailureprobablythroughitsinhibitionofcav12calciumchannelcurrents
AT juanyu shexiangbaoxinpillscouldalleviateisoproterenolinducedheartfailureprobablythroughitsinhibitionofcav12calciumchannelcurrents
AT jianyongqi shexiangbaoxinpillscouldalleviateisoproterenolinducedheartfailureprobablythroughitsinhibitionofcav12calciumchannelcurrents
AT minzhouzhang shexiangbaoxinpillscouldalleviateisoproterenolinducedheartfailureprobablythroughitsinhibitionofcav12calciumchannelcurrents